Significant improvements in psychological burden scores were noted among patients with pancreatobiliary cancers and their caregivers after participating in a support group.
The approval is supported by data from the phase 3 BEACON CRC trial in adults with BRAF V600E mutation-positive metastatic colorectal cancer with disease progression.
